Momentum ETF Posts Worst 5-Day Drop Since COVID; Monthly Underperformance Sets 40-Year Record
nashnova research
BlackRock's momentum ETF (MTUM) fell 14% in five days — the worst stretch since March 2020. JPMorgan data shows momentum underperformed the market by 10.8% in a single month, the widest gap since records began in 1985. This is not a routine pullback — it is a systematic factor unwind.
How bad is the damage?
MTUM's five-day return hit -14.02%, the worst since the Covid crash in March 2020 and the second-worst in the ETF's history.
At last report, shares traded at $64.13 — down roughly 26% from the June 22 high of $86.31.
This means → in under five months the fund lost a quarter of its peak value, far outpacing the broader market's decline over the same period.
What does a "six-sigma" unwind day actually mean?
A six-sigma event — a statistical outlier so extreme it should almost never occur — happened twice in a single week, triggered by mega-cap cloud earnings.
Momentum's monthly underperformance reached 5.8 standard deviations, the worst in over 40 years.
In plain terms = under a normal distribution, a six-sigma day should appear roughly once every few hundred thousand trading days. Two in one week signals a structural market reset, not random noise.
What does JPMorgan's long-run data show?
The cap-weighted momentum factor trailed the market by 10.8% in October — the largest single-month underperformance since JPMorgan's records began in 1985.
For context: the same factor beat the market by 9.8% in April 2026 and underperformed by about 7% during the 2008 financial crisis.
This means → this reversal is already more severe than 2008, and just six months ago momentum was leading by a wide margin — the sharper the run-up, the more violent the snapback.
What is inside this ETF?
The top ten holdings skew heavily toward tech and semiconductors: AMD at 5.80%, Micron at 4.70%, Cisco at 3.72%, Intel at 2.67%, Applied Materials at 2.59%.
Non-tech names include Johnson & Johnson (3.89%), ExxonMobil (3.06%), and UnitedHealth (2.43%), but at noticeably lower weights.
This reflects the fact that momentum screens over the past year selected mostly tech winners — when those names are sold en masse, the momentum ETF becomes a de-leveraging amplifier.
What to watch next?
The key question: if momentum stays under pressure, can the forced selling in the top-ten holdings be absorbed in the near term?
October 22, 2026 registered -6.63 standard deviations, the most extreme negative-sigma event in JPMorgan's tracking window (starting 2023).
In plain terms = the extreme event has already happened. The question going forward is not "will it fall?" but "how much forced-selling inventory is still left to clear?"
市场有风险，内容仅供研究参考，不构成投资建议。